marketcaparena
Search

    ATTO

    Attovia Therapeutics, Inc.

    Company overview

    Market capitalization
    $805.74M
    Employees
    —
    Latest publication
    2026-09-29

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Revenue450,000USD
    Research Development18,946,000USD
    Selling General Administrative3,307,000USD
    General And Administrative Expenses3,307,000USD
    Total Operating Expenses22,253,000USD
    Operating Income-21,803,000USD
    Total Other Income Expense Net1,116,000USD
    Interest Income1,141,000USD
    Net Income-20,687,000USD
    Net Income Applicable To Common Shares-20,687,000USD
    SourceDisclosureDeterministicFinal

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Assets128,348,000USD
    Cash And Equivalents32,829,000USD
    Total Current Assets118,401,000USD
    Other Current Assets3,269,000USD
    Other Non Current Assets2,622,000USD
    Total Liabilities15,581,000USD
    Total Current Liabilities12,615,000USD
    Other Current Liabilities4,575,000USD
    Other Non Current Liabilities678,000USD
    Total Stockholder Equity-145,459,000USD
    Total Equity Including Noncontrolling Interest112,767,000USD
    Deferred Revenue0USD
    Property Plant Equipment Net6,921,000USD
    Accounts Payable6,002,000USD
    Short Term Debt2,038,000USD
    Common Stock1,000USD
    Retained Earnings-150,353,000USD
    Accumulated Other Comprehensive Income-79,000USD
    SourceDisclosureDeterministicFinal

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Depreciation500,000USD
    Stock Based Compensation1,378,000USD
    Change To Liabilities2,035,000USD
    Change In Working Capital4,156,000USD
    Operating Cash Flow-34,932,000USD
    Capital Expenditures-361,000USD
    Net Investments29,726,000USD
    Investing Cash Flow29,365,000USD
    Financing Cash Flow-1,797,000USD
    Change In Cash-7,364,000USD
    End Cash Flow33,233,000USD
    SourceDisclosureDeterministicFinal

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    No revenue breakdown is currently published for this company.

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.